I reported previously (see here) on the Namodenoson (CF102) liver cancer treatment from Israel’s Can-Fite. After Phase 2 testing, a supply of CF102 has been manufactured for “compassionate use” on critically ill patients at Rabin Medical Center in Petah Tikva.

https://ir.canfite.com/press-releases/detail/862/can-fite-to-treat-advanced-liver-cancer-patients-with-namodenoson-under-compassionate-use-setting-in-israel